Nearly 600,000 Asthma Inhalers Recalled By GSK

ZEBULON, N.C. (CBS) – More than 593,000 asthma inhalers in the United States have been recalled because of a problem that could cause them to deliver less medication than intended. An FDA document indicates the reason for the recall is a “defective delivery system” due to a leak in the Ventolin inhalers. Reuters reports drugmaker GSK is trying to figure out what caused the problem after an increasing number of complaints, and is pulling the inhalers from hospitals, pharmacies, retailers and wholesalers. “Though the overall benefit-risk assessment for Ventolin® HFA 200D Inhaler when used at prescribed doses remains favourable, in this situation, there is possible risk to patients of experiencing diminished bronchodilation in the setting of acute bronchospasm if reliant on a rescue inhaler that could potentially not deliver the stated number of actuations,” GSK said in a statement posted on the Asthma and Allergy Foundation of America website. GlaxoSmithKline Recalling Ventolin Inhalers for Possible Package Leakage: #asthma — AAFA National (@AAFANational) April 5, 2017 GSK says patients using the inhalers are not in danger, so they don’t need to return the product. File photo of an inhaler (Photo by Getty Images) The recalled inhalers have a lot number of 6ZP9848, 6ZP0003 or 6ZP9944 and expire in March or April of 2018.
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Consumer Health News Asthma Recall Source Type: news

Related Links:

This study was conducted to evaluate the effect of Chlorpheniramine Maleate aerosol inhalation on flow volumes and gas exchange. Materials and Methods: 25 established patients of stabilized bronchial asthma (18 to 44 years) with history of EIA attending Allergy OPD, Medical OPD or Chest clinic were included in the present study. Patients were studied for 3 days in a week at the same time of day. Baseline spirometry was done to know test parameters, i.e. FEV1, PEFR and FEF50%. Gas exchange study during rest including minute ventilation (VE), oxygen consumption (VO2), Carbon dioxide produced per minute (VCO2), Respirator...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Dupilumab is a receptor antagonist binding to the alpha subunit of the interleukin-4 receptor. Through binding to it, dupilumab inhibits signaling of both IL-4 and IL-13, the representative Th2 biomarkers. Rec...
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Tags: Case report Source Type: research
The prevalence of asthma remains high worldwide, with increasing awareness of the morbidity and mortality from asthma in low-income countries. In the UK, despite the development of biological treatments, many patients remain suboptimally controlled, and mortality rates have been static for decades. Therefore, new approaches are needed to treat asthma that are scalable at minimal cost. Exercise immunology is an expanding field, and there is growing evidence that exercise can modulate inflammatory and immune processes in asthma. Whilst exercise is encouraged in current treatment guidelines, there are no specific recommendati...
Source: European Respiratory Review - Category: Respiratory Medicine Authors: Tags: Asthma and allergy Reviews Source Type: research
This article has an online data supplement.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research
A 2-year-old male, with a history significant for congenital cytomegalovirus, failure to thrive, pericardial effusion and chronic pulmonary hypertension of unknown etiology, reactive airway disease, and enteropathy with total parenteral nutrition-dependence, was initially evaluated for recurrent sinopulmonary infections and chronic mucocutaneous candidiasis (CMC). Two colonoscopies revealed pan-gastrointestinal inflammation, with suspicion that his enteropathy was related to an underlying immunodeficiency.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research
Asthma is a heterogeneous disease with emerging phenotypes and endotypes. Currently, five distinct biologics are Food and Drug Administration (FDA)-approved as add-on therapy for difficult-to-control Type 2-high asthma. As allergy specialists manage a spectrum of diseases for which biologics may be appropriate, it is important to understand their prescribing patterns.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
ConclusionsPatients with CRSwNP  + AS have distinct type 2-high inflammation-associated molecular signatures in nasal tissues compared to patients with CRSwNP-alone.
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research
Authors: Beasley R, Beckert L, Fingleton J, Hancox RJ, Harwood M, Hurst M, Jones S, Jones S, Kearns C, McNamara D, Poot B, Reid J Abstract The purpose of the 2020 Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines is to provide simple, practical and evidence-based recommendations for the diagnosis, assessment and management of asthma in adolescents and adults (aged 12 and over) in a quick reference format. The intended users are health professionals responsible for delivering asthma care in the community and hospital settings, and those responsible for the training of such health profession...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Publication date: Available online 24 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Javier Domínguez-Ortega, Valentín López-Carrasco, Pilar Barranco, Mihaela Ifim, Juan Alberto Luna, David Romero, Santiago Quirce
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
THURSDAY, July 2, 2020 -- The coronavirus pandemic makes planning for July 4th a challenge this year, especially if someone in the family has allergies or asthma, an allergy expert says. " This summer will see modifications in how people celebrate...
Source: - Daily MedNews - Category: General Medicine Source Type: news
More News: Allergy | Allergy & Immunology | Asthma | Health | Hospitals | Proair HFA | Sports Medicine | Ventolin | Websites